MedTrace Logo

Helping Ease Anxiety and Depression Following Stroke

NCT03956693 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2020-09-09

No results posted yet for this study

Summary

The aim of this mixed methods research is to conduct feasibility pilot testing of an existing mindfulness intervention called HEADS: UP. The intervention is designed to help people affected by stroke self-manage symptoms of anxiety and depression.

Conditions

Interventions

BEHAVIORAL

HEADS: UP

HEADS: UP comprises 9 x 2.5 hour mindfulness teaching sessions and a silent retreat in week 7. Course materials include accessible information packs and resources to complement class-based sessions. The first week of the 9-week course is an introductory class. The purpose of the introductory class is to give participants the opportunity to meet the trainers and to decide if they want to learn more about mindfulness. The introductory session also allows participants to meet other people on the course and to share their (stroke) stories.

Sponsors & Collaborators

  • University of Stirling

    collaborator OTHER

  • Edinburgh Napier University

    collaborator OTHER

  • The Stroke Association, United Kingdom

    collaborator OTHER

  • Yunus Centre for Social Business and Health

    collaborator UNKNOWN

  • University of Strathclyde

    collaborator OTHER

  • University of Manchester

    collaborator OTHER

  • Glasgow Caledonian University

    lead OTHER

Principal Investigators

  • Maggie Lawrence, PhD · Glasgow Caledonian University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2019-10-22
Completion
2020-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03956693 on ClinicalTrials.gov